Chemical Compound
DAUNORUBICIN CITRATE
CAS Registry Number
371770-68-2
Primary Record
DAUNORUBICIN CITRATE
- In stock
- 4,668 g
- Purity
- 99.5 %
- CAS
- 371770-68-2
Compound Identifiers & Properties
- CAS
- 371770-68-2
- PubChem CID
- 9961878
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=C(O)CC(O)(CC(=O)O)C(=O)O
Names & Synonyms
- DAUNORUBICIN CITRATE
- DaunoXome
- Daunorubicin liposomal
- DaunoXome (TN)
- Daunomycin(citrate)
- Daunorubicin (citrate)
- Daunorubicin citrate liposome
- UNII-5L84T2Z6NP
- RefChem:54933
- Daunorubicin citrate [MART.]
- 5L84T2Z6NP
- SCHEMBL42311
- Daunorubicin citrate [Orange Book]
- Daunorubicin citrate (MART.)
- DTXSID20190659
- orb1983522
- CHEMBL1200475
- SCHEMBL29354629
- DTXCID10113150
- BADC-01360
- DAUNORUBICIN CITRATE [WHO-DD]
- 371770-68-2
- CID9961878
- CID 9961878
- HY-108876
- CS-0031208
- DAUNORUBICIN CITRATE LIPOSOME [VANDF]
- D10787
- Q27262517
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;2-hydroxypropane-1,2,3-tricarboxylic acid
- 1884557-85-0
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
- 2-Hydroxypropane-1,2,3-tricarboxylic acid--(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1/1)
- 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S,10S)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
- 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S,10S)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1) (SALT)